Results 61 to 70 of about 196 (103)

A relevant feature combination assisted bi-level evolutionary multi-objective algorithm for feature selection in classification. [PDF]

Sci Rep
Xing L, Li J, Ma H, Su Z, Wu J.
europepmc   +1 more source

Teclistamab versus real-world physician's choice of therapy in triple-class exposed relapsed/refractory multiple myeloma. [PDF]

J Comp Eff Res, 2023
Krishnan A, Nooka AK, Chari A, Garfall AL, Martin TG, Nair S, Lin X, Qi K, Londhe A, Pei L, Ammann E, Kobos R, Smit J, Parekh T, Marshall A, Slavcev M, Usmani SZ.   +16 more
europepmc   +1 more source

High-Resolution Multiband 3D Imaging of Egyptian Papyri: Integrating Ultra-Close-Range Photogrammetry and Reflectance Transformation Imaging for Enhanced Documentation. [PDF]

Sensors (Basel)
Gargano M, Borghi G, Verni E, Maiocchi FG, Antoniazzi S, Goggi V, Grifoni E.   +6 more
europepmc   +1 more source

Isatuximab: A Review in Transplant-Ineligible Newly Diagnosed Multiple Myeloma. [PDF]

Target Oncol
Hoy SM.
europepmc   +1 more source

2019-2020 Drug Updates in Hematologic Malignancies. [PDF]

J Adv Pract Oncol, 2021
Finnes HD.
europepmc   +1 more source

Case Report: Reactive T-cell large granular lymphocytes in the bone marrow of a patient with relapsed/refractory multiple myeloma receiving teclistamab. [PDF]

Front Oncol
Dean EA, Yang LJ, Seifert RP, Wingard JR.   +3 more
europepmc   +1 more source

Refreshing the biologic pipeline 2020. [PDF]

Nat Biotechnol, 2021
Hodgson J.
europepmc   +1 more source

Comprehensive re-assembly and annotation dataset for the argan tree (Argania spinosa L., Sapotaceae) genome. [PDF]

Sci Data
Idrissi Azami A, Pirro S, Habib N, Unver T, Claros MG, Alché JD, Sehli S, El Ouafi Z, El Ghoubali D, Bousta D, Al Idrissi N, Gaboun F, Rfaki A, Legsyer A, Nejjari C, Amzazi S, Belyamani L, El Mousadik A, Ghazal H.   +18 more
europepmc   +1 more source

Predictive biomarkers and specific immune responses of COVID-19 mRNA vaccine in patients with cancer: prospective results from the CACOV-VAC trial. [PDF]

BMJ Oncol, 2023
Spehner L, Orillard E, Falcoz A, Lepiller Q, Bouard A, Almotlak H, Kim S, Curtit E, Meynard G, Jary M, Nardin C, Asgarov K, Abdeljaoued S, Chartral U, Mougey V, Ben Khelil M, Lopez M, Loyon R, Vernerey D, Adotevi O, Borg C, Mansi L, Kroemer M.   +22 more
europepmc   +1 more source

Redefining multiple myeloma treatment: Advances, challenges, and future directions in immunotherapy. [PDF]

Chin Med J (Engl)
Fu C, Zhai Y, Yan L, Jin S, Shang J, Shi X, Wu D.   +6 more
europepmc   +1 more source